{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:59:08Z","timestamp":1761843548977},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1990,10,1]],"date-time":"1990-10-01T00:00:00Z","timestamp":654739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1990,10]]},"DOI":"10.1007\/bf02427837","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T10:55:24Z","timestamp":1149677724000},"page":"159-163","source":"Crossref","is-referenced-by-count":20,"title":["Phase II study of homoharringtonine in patients with recurrent primary malignant central nervous system tumors"],"prefix":"10.1007","volume":"9","author":[{"given":"Lynn G.","family":"Feun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niramol","family":"Savaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Landy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Lampidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02427837_CR1","unstructured":"Smith CR, Mikolajczak KL, Powell RG: Harringtonine and related cephalotaxine esthers. Anticancer agents based on natural product models. Academic Press Inc Chapter II 391\u2013416"},{"key":"BF02427837_CR2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/jps.2600610812","volume":"61","author":"RG Powell","year":"1972","unstructured":"Powell RG, Wisleder D, Smith CR: Antitumor alkaloids from cephalotaxic harringtonine: structure and activity. J Pharm Sci 61: 1225\u20131230, 1972","journal-title":"J Pharm Sci"},{"key":"BF02427837_CR3","unstructured":"Clinical Brochure: Homoharringtonine (NSC-141633), Bethesda, MD, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, August, 1982"},{"key":"BF02427837_CR4","first-page":"314","volume":"35","author":"KE Mia","year":"1977","unstructured":"Mia KE, Lin LT, Chao TY: Studies of the alkaloids of cephalotaxus I. The isolation and characterization of antileukemic alkaloid together with a new alkaloid (+)-acetylcephalotaxine from cephalotaxus fortunei. Acta Clinical Sinica 35: 314, 201-208, 1977","journal-title":"Acta Clinical Sinica"},{"key":"BF02427837_CR5","first-page":"198","volume":"3","author":"RP Warrell Jr","year":"1984","unstructured":"Warrell RP Jr, Connley CJ, Gee TS: Homoharringtonine (HHT): An effective new drug for acute non-lymphoblastic leukemia (ANLL). Proc Amer Soc Clinc Oncol 3: 198, 1984","journal-title":"Proc Amer Soc Clinc Oncol"},{"key":"BF02427837_CR6","first-page":"289","volume":"24","author":"K Lu","year":"1983","unstructured":"Lu K, Savaraj N, Feun LG, Zhangang G, Loo TL: Pharmacokinetics of Homoharringtonine (HHT, NSC-141633) in dogs. Proc Am Asoc Can Res 24: 289, 1983","journal-title":"Proc Am Asoc Can Res"},{"key":"BF02427837_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00162769","volume":"5","author":"N Savaraj","year":"1987","unstructured":"Savaraj N, Feun LG, Lu K, Leavens M, Moser R, Fields WS, Loo TL: Central nervous system (CNS) Penetration of homoharringtonine (HHT) J Neuro-Onc. 5: 77\u201381, 1987","journal-title":"J Neuro-Onc."},{"key":"BF02427837_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00182961","volume":"1","author":"U Bogdahn","year":"1983","unstructured":"Bogdahn U: Chemosensitivity of malignant brain tumors: Preliminary results. J Neuro-Oncol 1: 149\u2013166, 1983","journal-title":"J Neuro-Oncol"},{"key":"BF02427837_CR9","first-page":"1085","volume":"68","author":"SS Legha","year":"1984","unstructured":"Legha SS, Keating M, Picket S,et al.: Phase I Clinical Investigation of Homoharringtonine. Cancer Treat Rep 68: 1085\u20131091, 1984","journal-title":"Cancer Treat Rep"},{"key":"BF02427837_CR10","first-page":"33","volume":"2","author":"MY Whitacre","year":"1983","unstructured":"Whitacre MY, VAN ECho DA, Applefield M, Wiernik PH, Aisener J: Phase I study of homoharringtonine (NSC 141633). Proc Amer Soc Clin Oncol 2: 33, 1983","journal-title":"Proc Amer Soc Clin Oncol"},{"key":"BF02427837_CR11","first-page":"1790","volume":"25","author":"SC Malmoud","year":"1984","unstructured":"Malmoud SC, Ohnuma T, Coffey V, Paincci PA, Wasserman LR, Holland JF: Phase I study of homoharringtonine (HHT) in 10 days schedule: 6 HR infusion daily vs continuous infusion. Proc Amer Assoc Can Res 25: 1790, 1984","journal-title":"Proc Amer Assoc Can Res"},{"key":"BF02427837_CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198301203080304","volume":"308","author":"P Selby","year":"1983","unstructured":"Selby P, Buick RN, Tannock I: A critical appraisal of the \u2018Human Tumor Stem-Cell Assay\u2019. N Engl J Med 308: 129\u2013155, 1983","journal-title":"N Engl J Med"},{"key":"BF02427837_CR13","first-page":"992","volume":"42","author":"WKA Yung","year":"1982","unstructured":"Yung WKA, Shapiro JR, Shapiro WR: Heterogeneous chemosensitivity of subpopulations of human glioma cells in culture. Cancer Res 42: 992\u2013998, 1982","journal-title":"Cancer Res"},{"key":"BF02427837_CR14","first-page":"145","volume":"1","author":"DJ Stewart","year":"1983","unstructured":"Stewart DJ, O'Brien RM, Al-Sarraf M,etal. Phase II study of cisplatin in recurrent astrocytomas in adults: A Southwest Oncology Group Study. J Neuro-Onc 1: 145\u2013147, 1983","journal-title":"J Neuro-Onc"},{"key":"BF02427837_CR15","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1097-0142(19840901)54:5<794::AID-CNCR2820540503>3.0.CO;2-F","volume":"54","author":"LG Feun","year":"1984","unstructured":"Feun LG, Wallace S, Stewart DJet al.: Intracarotid infusion of cisdiamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 54: 794\u2013799, 1984","journal-title":"Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02427837.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02427837\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02427837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T13:10:45Z","timestamp":1558098645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02427837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,10]]}},"alternative-id":["BF02427837"],"URL":"https:\/\/doi.org\/10.1007\/bf02427837","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,10]]}}}